Transcode Therapeutics shares owned by ACT Capital Management
Quarter-by-quarter ownership of Transcode Therapeutics shares owned by ACT Capital Management
from 13F filings
Historical chart of ACT Capital Management investment in Transcode Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Transcode Therapeutics held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Transcode Therapeutics by ACT Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-09-30 | $7.0k | 6.5k | 1.08 |
| 2022-06-30 | $8.0k | 6.5k | 1.23 |
| 2022-03-31 | $144k | 50k | 2.88 |
| 2021-12-31 | $127k | 50k | 2.54 |
| 2021-09-30 | $150k | 50k | 3.00 |